Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Canadian EdoxAban (Lixiana) Registry in Patients With ATrial Fibrillation With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)

Trial Profile

Canadian EdoxAban (Lixiana) Registry in Patients With ATrial Fibrillation With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Nov 2018

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms CAPTURE
  • Most Recent Events

    • 15 Nov 2018 Planned initiation date changed from 1 Sep 2018 to 1 Jan 2019.
    • 13 Jun 2018 Planned initiation date changed from 1 May 2018 to 1 Sep 2018.
    • 09 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top